These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15177548)

  • 1. Medical therapy of inflammatory bowel disease.
    Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):xv-xvi. PubMed ID: 15177548
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and future therapies for inflammatory bowel disease.
    Zisman TL; Kane SV
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):89-100. PubMed ID: 19072438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the management of inflammatory bowel disease.
    Grimpen F; Pavli P
    Intern Med J; 2010 Apr; 40(4):258-64. PubMed ID: 20059603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in inflammatory bowel disease.
    Hunter J
    Br J Hosp Med (Lond); 2007 Jul; 68(7):350. PubMed ID: 17663303
    [No Abstract]   [Full Text] [Related]  

  • 7. Current medical therapy for chronic inflammatory bowel diseases.
    Tamboli CP
    Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of inflammatory bowel diseases.
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2005 Jul; 21(4):443-7. PubMed ID: 15930985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic role of thalidomide in inflammatory bowel disease.
    Casella G; De Marco E; Monti C; Baldini V
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):293-301. PubMed ID: 16971873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the drug treatment regimens for inflammatory bowel disease.
    Brock EM; Zabihollah M
    Expert Opin Pharmacother; 1999 Nov; 1(1):15-8. PubMed ID: 11249558
    [No Abstract]   [Full Text] [Related]  

  • 13. Overlapping functional syndromes: a way forward for medical therapy?
    Stanghellini V
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():138. PubMed ID: 18924457
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between the IGF system and inflammatory markers in inflammatory bowel disease.
    Grønbaek H; Eivindson MV
    Aliment Pharmacol Ther; 2006 Feb; 23(4):553-4; author reply 554-5. PubMed ID: 16441476
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppresive therapy for inflammatory bowel disease.
    Casis Herce B
    Rev Esp Enferm Dig; 2003 Jul; 95(7):456-8, 453-5. PubMed ID: 12952507
    [No Abstract]   [Full Text] [Related]  

  • 17. Are we ready for top-down therapy for inflammatory bowel diseases: con.
    Herfarth H
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):249-55. PubMed ID: 19072417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 targeted therapy in inflammatory bowel disease.
    Yarkoni S; Sagiv Y; Kaminitz A; Askenasy N
    Gut; 2009 Dec; 58(12):1705-6. PubMed ID: 19923351
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease.
    Barta Z; Zöld E; Zeher M
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1363-4; author reply 1364. PubMed ID: 17509104
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of cyclosporine therapy in inflammatory bowel disease.
    Cullen G; Keegan D; O'Donoghue D
    Am J Gastroenterol; 2008 Oct; 103(10):2654-5; author reply 2655. PubMed ID: 18855861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.